{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T20:10:01Z","timestamp":1746907801909,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007705","name":"Astellas Pharma Global Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007705","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacig.2025.100404","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:30:50Z","timestamp":1736296250000},"page":"100404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phase 1 study of safety, tolerability, and efficacy of intradermal DNA vaccine ASP2390 in adults allergic to house dust mites"],"prefix":"10.1016","volume":"4","author":[{"given":"Thomas","family":"Kayser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kusawake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Wambre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurunadh R.","family":"Chichili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Blauwet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Patton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Tabash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah A.","family":"DeBerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sugandhika","family":"Khosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Badorrek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-6186","authenticated-orcid":false,"given":"Jens M.","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Ferslew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100404_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1939-4551-7-12","article-title":"Allergic diseases and asthma: a global public health concern and a call to action","volume":"7","author":"Pawankar","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2025.100404_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaci.2014.10.012","article-title":"Respiratory allergy caused by house dust mites: what do we really know?","volume":"136","author":"Calder\u00f3n","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.alit.2015.05.004","article-title":"Hierarchy and molecular properties of house dust mite allergens","volume":"64","author":"Thomas","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.jacig.2025.100404_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1365-2362.2008.02048.x","article-title":"Variability of IgE reactivity profiles among European mite allergic patients","volume":"38","author":"Weghofer","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacig.2025.100404_bib5","first-page":"104","article-title":"Differential IgE reactivity to Der p 1 and Der p 2 allergens of Dermatophagoides pteronyssinus in mite-sensitized patients","volume":"16","author":"Taketomi","year":"2006","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/all.15553","article-title":"Specific IgE against the house dust mite allergens Der p 5, 20 and 21 influences the phenotype and severity of atopic diseases","volume":"78","author":"Walsemann","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100404_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/alr.23090","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis\u20142023","volume":"13","author":"Wise","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jacig.2025.100404_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1398-9995.2008.01690.x","article-title":"House dust mite control measures for asthma: systematic review","volume":"63","author":"G\u00f8tzsche","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100404_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5414\/ALX02331E","volume":"6","author":"Pfaar","year":"2022","journal-title":"Allergol Select"},{"key":"10.1016\/j.jacig.2025.100404_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/ACI.0000000000000536","article-title":"Recombinant allergens for immunotherapy: state of the art","volume":"19","author":"Zhernov","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib11","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1080\/21645515.2017.1367882","article-title":"Next generation immunotherapy for tree pollen allergies","volume":"13","author":"Su","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jacig.2025.100404_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","article-title":"Allergen immunotherapy: past, present and future","volume":"23","author":"Durham","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib13","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.155.4.1818","article-title":"Lysosome-associated membrane protein-1\u2013mediated targeting of the HIV-1 envelope protein to an endosomal\/lysosomal compartment enhances its presentation to MHC class II\u2013restricted T cells","volume":"155","author":"Rowell","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib14","doi-asserted-by":"crossref","first-page":"11671","DOI":"10.1073\/pnas.92.25.11671","article-title":"Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens","volume":"92","author":"Wu","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacig.2025.100404_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4857869","article-title":"CryJ-LAMP DNA vaccines for Japanese red cedar allergy induce robust Th1-type immune responses in murine model","volume":"2016","author":"Su","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jacig.2025.100404_bib16","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1080\/21645515.2017.1329070","article-title":"Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: a phase I study","volume":"13","author":"Su","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jacig.2025.100404_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.12.1482","article-title":"Immunization with ARA h 1, 2, 3\u2013Lamp-Vax peanut vaccine blocked IgE mediated anaphylaxis in a peanut allergic murine model","volume":"135","author":"Li","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.12.1403","article-title":"Lamp-based DNA vaccine for Japanese red cedar allergy","volume":"135","author":"Su","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1472-9733.2012.01164.x","article-title":"Experience with an allergen challenge chamber for clinical trials in allergic rhinitis","volume":"12","author":"Krug","year":"2012","journal-title":"Clin Exp Allergy Rev"},{"key":"10.1016\/j.jacig.2025.100404_bib20","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/all.12947","article-title":"Safety, efficacy and repeatability of a novel house dust mite allergen challenge technique in the Fraunhofer allergen challenge chamber","volume":"71","author":"Lueer","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100404_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System","volume":"125","author":"Cox","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/all.15931","article-title":"Safety and immunopharmacology of ASP0892 in adults or adolescents with peanut allergy: two randomized trials","volume":"79","author":"Ferslew","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100404_bib24","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1159\/000531878","article-title":"Sodium chloride versus lactose as a carrier for house dust mite allergen in allergen chamber studies: a clinical study to assess noninferiority","volume":"184","author":"Stru\u00df","year":"2023","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2015.06.036","article-title":"Effective treatment of house dust mite\u2013induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"137","author":"Demoly","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100404_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40629-018-0058-y","article-title":"Positive and negative AIT trials: what makes the difference?","volume":"27","author":"van Gerth Wijk","year":"2018","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jacig.2025.100404_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00105-017-3937-0","article-title":"Placeboeffekt in Studien zur allergenspezifischen Immuntherapie mit Inhalationsallergenen","volume":"68","author":"Wedi","year":"2017","journal-title":"Hautarzt"},{"key":"10.1016\/j.jacig.2025.100404_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/all.14331","article-title":"Placebo effects in allergen immunotherapy\u2014an EAACI Task Force position paper","volume":"76","author":"Pfaar","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100404_bib29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1365-2222.2010.03498.x","article-title":"Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions","volume":"40","author":"Hohlfeld","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2025.100404_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5414\/CPP47071","article-title":"A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis","volume":"47","author":"Badorrek","year":"2009","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T19:42:48Z","timestamp":1746906168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829325000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2772829325000050"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100404","relation":{},"ISSN":["2772-8293"],"issn-type":[{"type":"print","value":"2772-8293"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 1 study of safety, tolerability, and efficacy of intradermal DNA vaccine ASP2390 in adults allergic to house dust mites","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100404"}}